Amyloid Solution Inc.
PrivateLast Round
Series C
May 18, 2022
Est. Valuation
$193.7M
Total Funding Raised
$66.6M
Company Overview
Amyloid Solution Inc. operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series C round in May 2022.
Amyloid Solution Inc. is a biotechnology company that develops therapeutic drugs for the treatment of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amyloid Solution Inc. Comparables
Compare Amyloid Solution Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AriBio | 88% | |
| Adel, Inc. | 81% | |
| Alzheon | 79% |
For institutional investors. Book with your work email.
Amyloid Solution Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 18, 2022 | ||||
| Series B Extension | Jun 20, 2020 | ||||
| Series B | Apr 10, 2020 | ||||
| Series A | Mar 26, 2019 | ||||
| Accelerator | Dec 1, 2017 |
For institutional investors. Book with your work email.
Amyloid Solution Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Investment | Series B Extension |
| POSCO Capital | Series B Extension, Series C |
| KCLAVIS Investment | Series B |
| Starset Investment | Series A |
| TS Investment | Series A, Series B, Series C |
| Innopolis Partners | Series A |
| Wonik Investment Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2025
Presented lead programs at the Alzheimer's Association International Conference 2025.
- May 18, 2022
$35.5M round with participation from POSCO Capital.
For institutional investors. Book with your work email.
Amyloid Solution Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amyloid Solution Inc.'s valuation, stock price, and market status.
Is Amyloid Solution Inc. a public or private company?
Amyloid Solution Inc. is a private company.
What is the current stock price of Amyloid Solution Inc.?
Amyloid Solution Inc. is a private company, so its shares have no public market price. Caplight tracks Amyloid Solution Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amyloid Solution Inc. worth (valuation)?
Amyloid Solution Inc.'s valuation is estimated at $193.7M based on funding round data.
Can I buy Amyloid Solution Inc. stock?
Amyloid Solution Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amyloid Solution Inc.'s last funding round?
Amyloid Solution Inc.'s most recent funding round was Series C on May 18, 2022.
Who are the main investors in Amyloid Solution Inc.?
Key investors in Amyloid Solution Inc. include Korea Development Bank.
Will Amyloid Solution Inc. IPO soon?
No public IPO plans have been announced for Amyloid Solution Inc..
How can I track Amyloid Solution Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Amyloid Solution Inc.'s shares on secondary markets.